Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma

被引:0
作者
Villarruel-Melquiades, Fernanda [1 ]
Aguirre-Maldonado, Isaac [1 ,2 ]
Herrera-Lopez, Ema Elvira [1 ,2 ]
Mendoza-Garrido, Maria Eugenia [3 ]
Perez-Carreor, Julio Isael [2 ]
Banuelos, Cecilia [4 ]
Camacho, Javier [1 ]
机构
[1] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Farmacol, Ave IPN 2508, Ciudad De Mexico 07360, Mexico
[2] Inst Nacl Med Genom INMEGEN, Ciudad De Mexico 14610, Mexico
[3] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Ciudad De Mexico 07360, Mexico
[4] Inst Politecn Nacl, Programa Transdisciplinario Desarrollo Cient & Tec, Ctr Invest & Estudios Avanzados, Dept Invest & Estudios Multidisciplinarios, Ciudad De Mexico 07360, Mexico
关键词
Activator protein-1; liver pathology; hepatocellular carcinoma; liver carcinogenesis; transcription factors; VIRUS X-PROTEIN; MATRIX METALLOPROTEINASE-1 EXPRESSION; NF-KAPPA-B; C-JUN; TRANSCRIPTION FACTOR; HEPATITIS-B; CYCLIN D1; MATRIX-METALLOPROTEINASE-9; GENE; CELL-PROLIFERATION; SIGNALING PATHWAY;
D O I
10.20517/2394-5079.2024.95
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activator protein 1 (AP-1) is a family of transcription factors composed of Jun, Fos, activating transcription factor (ATF), and musculoaponeurotic fibrosarcoma (MAF) homodimers and heterodimers that regulate diverse cellular processes such as proliferation, apoptosis, differentiation, survival, and migration. Accordingly, AP-1 plays an essential role in several diseases including cancer. During liver cancer development, AP-1 abnormal activation has been implicated from cancer initiation to cancer progression. This review aims to provide a current integrative understanding of the role of AP-1 in liver carcinogenesis and suggests potential settings for its clinical use in diagnosis and treatment. Novel AP-1-based therapeutic approaches deserve further investigation and clinical application for the benefit of liver cancer patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [11] The Expression Patterns and Clinical Significance of microRNAs in Liver Diseases and Hepatocellular Carcinoma
    Guo, Jinsheng
    Friedman, Scott L.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (07) : 1262 - 1272
  • [12] The MAPK-activator protein-1 signaling regulates changes in lung tissue of rat exposed to hypobaric hypoxia
    Singh, Mrinalini
    Yadav, Seema
    Kumar, Meetul
    Saxena, Shweta
    Saraswat, Deepika
    Bansal, Anju
    Singh, Shashi B.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (10) : 6851 - 6865
  • [13] Fukutin Protein Participates in Cell Proliferation by Enhancing Cyclin D1 Expression through Binding to the Transcription Factor Activator Protein-1: An In Vitro Study
    Okamura, Yukinori
    Yamamoto, Tomoko
    Tsukui, Ryota
    Kato, Yoichiro
    Shibata, Noriyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [14] Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma
    Arai, Eri
    Ushijima, Saori
    Gotoh, Masahiro
    Ojima, Hidenori
    Kosuge, Tomoo
    Hosoda, Fumie
    Shibata, Tatsuhiro
    Kondo, Tadashi
    Yokoi, Sana
    Imoto, Issei
    Inazawa, Johji
    Hirohashi, Setsuo
    Kanai, Yae
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (12) : 2854 - 2862
  • [15] Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development
    Nayeb-Hashemi, Hamed
    Desai, Anal
    Demchev, Valeriy
    Bronson, Roderick T.
    Hornick, Jason L.
    Cohen, David E.
    Ukomadu, Chinweike
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 465 (02) : 167 - 173
  • [16] Activator protein-1 is a novel regulator of mesencephalic astrocyte-derived neurotrophic factor transcription
    Wang, Chang-Hui
    Jiang, Tong-Cui
    Qiang, Wei-Min
    Zhang, Li
    Feng, Li-Jie
    Shen, Yu-Jun
    Shen, Yu-Xian
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5765 - 5774
  • [17] The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma
    Hua, Nanni
    Chen, Anxian
    Yang, Chen
    Dong, Hui
    He, Xianglei
    Ru, Guoqing
    Tong, Xiangmin
    Zhou, Feifei
    Wang, Shibing
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (08) : 7911 - 7919
  • [18] The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma
    Nanni Hua
    Anxian Chen
    Chen Yang
    Hui Dong
    Xianglei He
    Guoqing Ru
    Xiangmin Tong
    Feifei Zhou
    Shibing Wang
    Molecular Biology Reports, 2022, 49 : 7911 - 7919
  • [19] The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice
    Bitton-Worms, Keren
    Pikarsky, Eli
    Aronheim, Ami
    MOLECULAR CANCER, 2010, 9
  • [20] Hepatocellular Carcinoma SurveillanceExperience from Croatian Referral Centre for Chronic Liver Diseases
    Majerovic, Matea
    Jelakovic, Mislav
    Premuzic, Marina
    Stromar, Ivana Knezevic
    Radic, Davor
    Mance, Marko
    Plestina, Stjepko
    Ostojic, Rajko
    Rustemovic, Nadan
    Krznaric, Zeljko
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 48 - 53